Chan K N, Silverman M
Department of Paediatrics and Neonatal Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.
Arch Dis Child. 1993 Jul;69(1):120-4. doi: 10.1136/adc.69.1.120.
The effect of treatment with topical inhaled corticosteroids was assessed in 15 children of low birth weight (mean (SD) birth weight 1435 (268) g, gestational age 30.5 (2.9) weeks, age at study 8.2 (0.4) years) who were symptomatic and showed a positive airway response to histamine aerosol. The study was of a double blind, placebo controlled, crossover design with four week long treatment periods with inhaled beclomethasone dipropionate (400 micrograms daily) or placebo. Daily symptom scores were recorded and physiological measurements were performed at the beginning and end of each treatment period. There was no significant difference in respiratory symptom score, baseline airway function, or the airway response to histamine between treatment periods. The findings argue against an inflammatory basis for airway hyper-responsiveness in these children and raise questions as to its pathophysiological basis.
对15名低出生体重儿童(平均(标准差)出生体重1435(268)克,胎龄30.5(2.9)周,研究时年龄8.2(0.4)岁)进行了局部吸入皮质类固醇治疗的效果评估,这些儿童有症状且对组胺气雾剂气道反应呈阳性。该研究采用双盲、安慰剂对照、交叉设计,吸入丙酸倍氯米松(每日400微克)或安慰剂的治疗期为四周。记录每日症状评分,并在每个治疗期开始和结束时进行生理测量。治疗期之间,呼吸症状评分、基线气道功能或气道对组胺的反应无显著差异。这些发现不支持这些儿童气道高反应性的炎症基础,并对其病理生理基础提出了疑问。